These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1850041)

  • 1. Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.
    Powdrill TF; Johnston JM
    J Virol; 1991 May; 65(5):2686-90. PubMed ID: 1850041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
    Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
    J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
    Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
    Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a hepatitis A virus strain suitable for vaccine production.
    Fineschi N; Cavalieri F; Garelick H; Prugnola A; Pellegrini V; Zuckerman AJ
    J Hepatol; 1991; 13 Suppl 4():S146-51. PubMed ID: 1668326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens.
    Ross BC; Anderson DA
    J Virol Methods; 1991 May; 32(2-3):213-20. PubMed ID: 1651950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.
    Stapleton JT; Raina V; Winokur PL; Walters K; Klinzman D; Rosen E; McLinden JH
    J Virol; 1993 Feb; 67(2):1080-5. PubMed ID: 7678298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus.
    Jang KO; Park JH; Lee HH; Chung DK; Kim W; Chung IS
    Protein Expr Purif; 2014 Aug; 100():1-9. PubMed ID: 24816194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein.
    Ostermayr R; von der Helm K; Gauss-Müller V; Winnacker EL; Deinhardt F
    J Virol; 1987 Nov; 61(11):3645-7. PubMed ID: 2822970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatitis A virus proteins in infected BS-C-1 cells.
    Updike WS; Tesar M; Ehrenfeld E
    Virology; 1991 Nov; 185(1):411-8. PubMed ID: 1656592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies.
    Hoatlin ME; Kew OM; Renz ME
    J Virol; 1987 May; 61(5):1442-7. PubMed ID: 3033273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
    Emini EA; Hughes JV; Perlow DS; Boger J
    J Virol; 1985 Sep; 55(3):836-9. PubMed ID: 2991600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of retro-inverso peptides as synthetic vaccines.
    Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
    Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate recombinant vaccine for human B19 parvovirus.
    Bansal GP; Hatfield JA; Dunn FE; Kramer AA; Brady F; Riggin CH; Collett MS; Yoshimoto K; Kajigaya S; Young NS
    J Infect Dis; 1993 May; 167(5):1034-44. PubMed ID: 8486937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.
    Ping LH; Jansen RW; Stapleton JT; Cohen JI; Lemon SM
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8281-5. PubMed ID: 2460866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein.
    Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial expression of the major antigenic regions of porcine rotavirus VP7 induces a neutralizing immune response in mice.
    Wang L; Huang JA; Nagesha HS; Smith SC; Phelps A; Holmes I; Martyn JC; Coloe PJ; Reeves PR
    Vaccine; 1999 Jun; 17(20-21):2636-45. PubMed ID: 10418913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.